ATE79114T1 - Aromatische und heterocyclische carboxamide als antineoplastische mittel. - Google Patents

Aromatische und heterocyclische carboxamide als antineoplastische mittel.

Info

Publication number
ATE79114T1
ATE79114T1 AT89305141T AT89305141T ATE79114T1 AT E79114 T1 ATE79114 T1 AT E79114T1 AT 89305141 T AT89305141 T AT 89305141T AT 89305141 T AT89305141 T AT 89305141T AT E79114 T1 ATE79114 T1 AT E79114T1
Authority
AT
Austria
Prior art keywords
aromatic
antineoplastic agents
heterocyclic carboxamides
carboxamides
heterocyclic
Prior art date
Application number
AT89305141T
Other languages
English (en)
Inventor
Anton Franz Josef Fliri
Rodney Caughren Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE79114T1 publication Critical patent/ATE79114T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Graft Or Block Polymers (AREA)
AT89305141T 1988-05-24 1989-05-22 Aromatische und heterocyclische carboxamide als antineoplastische mittel. ATE79114T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19803488A 1988-05-24 1988-05-24
EP89305141A EP0343893B1 (de) 1988-05-24 1989-05-22 Aromatische und heterocyclische Carboxamide als antineoplastische Mittel

Publications (1)

Publication Number Publication Date
ATE79114T1 true ATE79114T1 (de) 1992-08-15

Family

ID=22731735

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89305141T ATE79114T1 (de) 1988-05-24 1989-05-22 Aromatische und heterocyclische carboxamide als antineoplastische mittel.

Country Status (25)

Country Link
EP (1) EP0343893B1 (de)
JP (1) JPH0678331B2 (de)
KR (1) KR910006864B1 (de)
CN (1) CN1023700C (de)
AT (1) ATE79114T1 (de)
AU (1) AU601905B2 (de)
CA (1) CA1328871C (de)
DD (1) DD283815A5 (de)
DE (1) DE68902358T2 (de)
DK (1) DK249389A (de)
ES (1) ES2043012T3 (de)
FI (1) FI892498A7 (de)
GR (1) GR3005844T3 (de)
HU (1) HU202507B (de)
IE (1) IE891667L (de)
IL (1) IL90337A0 (de)
MX (1) MX173140B (de)
MY (1) MY106035A (de)
NO (1) NO172389C (de)
NZ (1) NZ229234A (de)
PL (1) PL154875B1 (de)
PT (1) PT90622B (de)
SU (1) SU1681728A3 (de)
YU (1) YU47019B (de)
ZA (1) ZA893862B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2790299B2 (ja) * 1989-02-01 1998-08-27 保土谷化学工業株式会社 ペンゾチアゾール誘導体
US5262400A (en) * 1991-06-20 1993-11-16 Merck & Co., Inc. 4α-substituted avermectin derivatives
ATE203234T1 (de) 1995-08-30 2001-08-15 Searle & Co Meta-guanidine, harnstoff, thioharnstoff oder azacyklische aminobenzoesäure-derivate als integrin antagonisten
US6100423A (en) * 1995-08-30 2000-08-08 G. D. Searle & Co. Amino benzenepropanoic acid compounds and derivatives thereof
US5716281A (en) * 1995-11-27 1998-02-10 Sega Enterprises, Ltd. Game apparatus using a vehicle with an optical image synthesizing system
TW513418B (en) * 1996-07-31 2002-12-11 Otsuka Pharma Co Ltd Thiazole derivatives, their production and use
ID24289A (id) 1997-11-10 2000-07-13 Bristol Myers Squibb Co Benzotiazol inhibitor-inhibitor protein terosin kinase
SI0928793T1 (en) * 1998-01-02 2002-10-31 F. Hoffmann-La Roche Ag Thiazole derivatives
AU3406599A (en) * 1998-04-09 1999-11-01 Institut Fur Diagnostikforschung Gmbh An Der Freien Universitat Berlin Novel benzyl guanidine derivatives for therapy and (in-vivo) and (in-vitro) diagnosis
JP3886897B2 (ja) 2000-06-21 2007-02-28 エフ．ホフマン−ラ ロシュ アーゲー ベンゾチアゾール誘導体
US6620811B2 (en) * 2001-11-19 2003-09-16 Hoffmann-La Roche Inc. Isonicotin- and nicotinamide derivatives of benzothiazoles
US6599901B1 (en) * 2001-11-19 2003-07-29 Hoffman-La Roche Inc. Pyridone substituted benzothiazole derivatives
US6624163B2 (en) * 2001-11-29 2003-09-23 Hoffman-La Roche Inc. Benzothiazole derivatives
GB0130868D0 (en) * 2001-12-24 2002-02-06 Univ Strathclyde New compounds
CN100357283C (zh) * 2002-04-02 2007-12-26 中国科学院上海药物研究所 一类甲硫氨酰氨肽酶抑制剂
US7087761B2 (en) 2003-01-07 2006-08-08 Hoffmann-La Roche Inc. Cyclization process for substituted benzothiazole derivatives
PL1636217T3 (pl) * 2003-05-13 2009-02-27 Hoffmann La Roche 1-Imidazobenzotiazole jako ligandy receptora adenozynowego
SI1636223T1 (sl) * 2003-05-19 2008-06-30 Hoffmann La Roche Derivati benzotiazola kot ligandi receptorja adenozina
KR100765565B1 (ko) * 2003-05-21 2007-10-09 에프. 호프만-라 로슈 아게 벤조티아졸 유도체 및 그의 아데노신 에이2에이 수용체에관련된 질병의 치료에서의 용도
ATE396726T1 (de) * 2003-05-30 2008-06-15 Hoffmann La Roche Benzothiazole derivate und ihre anwendung in der behandlung von adenosine a2a rezeptor vermittelte krankheiten
KR20060054408A (ko) * 2003-07-28 2006-05-22 얀센 파마슈티카 엔.브이. 벤즈이미다졸, 벤즈티아졸 및 벤즈옥사졸 유도체 및ｌｔａ4 ｈ 조정자로서의 그의 용도
PT1753760E (pt) 2004-05-24 2008-02-12 Hoffmann La Roche '' - metoxi - 7 - morfolin - 4 - il - benzotiazol - 2 - il) - amida do ácido 4 - hidroxi - 4 - metil - piperidina - 1 - carboxílico''
JP2008506735A (ja) * 2004-07-22 2008-03-06 エフ．ホフマン−ラ　ロシュ　アーゲー 置換されているベンゾチアゾール類
JP5202946B2 (ja) * 2004-07-22 2013-06-05 エフ．ホフマン−ラ ロシュ アーゲー ベンゾチアゾール誘導体
US7459563B2 (en) 2004-11-05 2008-12-02 Hoffmann-La Roche Inc. Process for the preparation of isonicotinic acid derivatives
DK1863818T3 (da) 2005-03-23 2010-05-10 Hoffmann La Roche Acetylenyl-pyrazolo-pyrimidinderivater som mglur2-antagonister
KR101121292B1 (ko) 2005-09-27 2012-04-13 에프. 호프만-라 로슈 아게 Ｍｇｌｕｒ2 길항제로서 옥사다이아졸일 피라졸로-피리미딘
WO2007104557A2 (en) * 2006-03-15 2007-09-20 4Sc Ag Novel heterocyclic nf-kb inhibitors
GB0619325D0 (en) 2006-09-30 2006-11-08 Univ Strathclyde New compounds
EP2303886A2 (de) * 2008-06-24 2011-04-06 Takeda Pharmaceutical Company Limited Pi3k/m tor-hemmer
US9499790B2 (en) 2010-08-26 2016-11-22 Kyoto University Method for promoting differentiation of pluripotent stem cells into cardiac muscle cells
AU2012315953A1 (en) * 2011-09-30 2014-04-03 Kineta, Inc. Anti-viral compounds
EP2808383B1 (de) 2012-01-27 2018-07-25 Kyoto University Verfahren zur induktion der kardialen differenzierung pluripotenter stammzellen
JP6351567B2 (ja) 2013-03-08 2018-07-04 国立大学法人京都大学 Ｅｇｆ受容体阻害剤を含む多能性幹細胞の心筋分化促進剤
WO2015037706A1 (ja) * 2013-09-13 2015-03-19 国立大学法人京都大学 多能性幹細胞の心筋分化を促進する化合物
WO2015182765A1 (ja) 2014-05-30 2015-12-03 国立大学法人京都大学 低分子化合物を用いた多能性幹細胞の心筋分化誘導法
CN109776486A (zh) * 2019-02-26 2019-05-21 武汉松石科技股份有限公司 一种硫酸亚丙酯的制备方法
CN110590735B (zh) * 2019-09-30 2021-07-23 江苏国泰超威新材料有限公司 一种环状硫酸酯的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61225168A (ja) * 1985-03-30 1986-10-06 Nippon Tokushu Noyaku Seizo Kk 新規ベンズアミド、その製法及び殺虫剤
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
GB8611606D0 (en) * 1986-05-13 1986-06-18 Fbc Ltd Fungicides

Also Published As

Publication number Publication date
MX16158A (es) 1993-06-01
CN1023700C (zh) 1994-02-09
KR910006864B1 (ko) 1991-09-09
PT90622B (pt) 1994-10-31
IL90337A0 (en) 1989-12-15
KR890017248A (ko) 1989-12-15
DK249389A (da) 1989-11-27
HU202507B (en) 1991-03-28
NO172389B (no) 1993-04-05
DK249389D0 (da) 1989-05-23
DE68902358T2 (de) 1992-12-10
ES2043012T3 (es) 1993-12-16
NO892059L (no) 1989-11-27
PL154875B1 (en) 1991-09-30
JPH0678331B2 (ja) 1994-10-05
JPH0217181A (ja) 1990-01-22
SU1681728A3 (ru) 1991-09-30
NZ229234A (en) 1990-09-26
ZA893862B (en) 1991-01-30
EP0343893B1 (de) 1992-08-05
FI892498A0 (fi) 1989-05-23
CA1328871C (en) 1994-04-26
EP0343893A1 (de) 1989-11-29
IE891667L (en) 1989-11-24
YU105989A (en) 1990-08-31
NO892059D0 (no) 1989-05-23
CN1037898A (zh) 1989-12-13
MY106035A (en) 1995-03-31
PT90622A (pt) 1989-11-30
AU601905B2 (en) 1990-09-20
DE68902358D1 (de) 1992-09-10
DD283815A5 (de) 1990-10-24
GR3005844T3 (de) 1993-06-07
FI892498A7 (fi) 1989-11-25
YU47019B (sh) 1994-11-15
HUT51606A (en) 1990-05-28
NO172389C (no) 1993-07-14
MX173140B (es) 1994-02-02
AU3509889A (en) 1989-11-30
PL279613A1 (en) 1989-11-27

Similar Documents

Publication Publication Date Title
ATE79114T1 (de) Aromatische und heterocyclische carboxamide als antineoplastische mittel.
DK143986A (da) 1,2-benzisoxazol-3-yl- og 1,2-benzisothiazol-3-yl-derivater
DK173486D0 (da) Heterocykliske amidderivater
DE68914197D1 (de) Alkansäurederivate und herbizide Mittel.
DE68927417D1 (de) Oligoribonukleotid-Derivate und ihre Anwendung als antivirale Mittel
FI970112A0 (fi) Helico-bakeerin vastaisia atsolonien asyylijohdannaisia
DE3671434D1 (de) Phenylalaninderivate und proteinaseinhibitor.
DE69030030D1 (de) 4-Acyloxychinolin-Derivate und diese enthaltende insektizide und akarizide Mittel
DE3875866D1 (de) Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie.
DE68926733D1 (de) Piperidin-Derivate und diese enthaltende Hypotensiva
DE68909501D1 (de) Hydroxyalkylcystein-derivate und diese enthaltende expectoranzien.
DK455288D0 (da) Acylderivater
DE3782636D1 (de) Isoindolin-1-on-derivat und antiarrhythmisches mittel.
DE68929321D1 (de) Therapeutische Anwendungen von 2',5'-Oligoadenylat-Derivaten
DK170088D0 (da) Acylderivater
DE68919512D1 (de) Chinoxalin-Derivate und antiulzerierendes Mittel.
DE59009786D1 (de) Temperatur- und versorgungsspannungsunabhängige Multivibratorschaltung.
DE3671630D1 (de) Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate.
DE3852245D1 (de) Isoprenderivate und diese enthaltende Anti-Ulcus-Mittel.
DE3769332D1 (de) Derivate von pyrido-menadion-additionsprodukten und verwendungen davon.
DE3688032D1 (de) Amidderivate und diese enthaltende 5-lipoxygenase-inhibitoren.
FI950303L (fi) Pyridoindolobentsodiatsepiinit ja johdannaiset antipsykoottisina aineina
DE69123168D1 (de) Piperidinderivate und diese enthaltende Antiulcer-Präparate
LV5778B4 (lv) 1,2-Benzizoksazol-3-il- un 1,2-benzizotiazol-3-il-atvasinajumi
ATE109773T1 (de) Acylierungsprodukte von 9,10-

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee